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This review presents the history of discoveries concerning the pancreas. In antiquity and the Middle Ages knowledge about the 
anatomy of the pancreas was very limited and its function was completely unknown. Significant progress was first made in the 
seventeenth and eighteenth centuries. Johann Georg Wirsung, the prosector of the University of Padua, discovered the main 
pancreatic duct, and Giovanni Santorini discovered the accessory duct. Regnier de Graafwas the first to perform pancreatic exocrine 
studies, and Paul Langerhans’s 1869 discovery of pancreatic islets was the first step toward recognizing the pancreas as an endocrine 
gland. The twentieth century brought the discovery of insulin and other pancreatic hormones. To date, histochemical staining, 
transmission electron microscopy, and immunohistochemistry enabled the discovery of five cell types with identified hormonal 
products in adult human pancreatic islets. Twentieth-century pancreatic studies led to crucial advances in scientific knowledge and 
were recognized, among other things, with seven Nobel Prizes. The first of these went to Ivan Pavlov in 1904 for his work on the 
physiology of digestion. The most recent was awarded to Gunter Blobel in 1999 for discovering signaling mechanisms that govern 
the transport and localization of proteins within pancreatic acinar cells.
1. Introduction
The term “pancreas” derives from Greek and consists of two 
words: παν (pan), meaning all, κρέας (kreas), meaning flesh. 
“Pancreas” thus means “all flesh” [1] and probably reflects the 
organ’s uniform texture. It remains uncertain, however, who 
first discovered the pancreas and used the term “pancreas” to 
refer to it. The discovery is typically attributed to Herophilus 
of Chalcedon, who is widely considered to be the father of 
anatomy, and who lived at the turn of the fourth and third 
centuries B.C.E. [2 ]. Unfortunately, none of his works have 
been preserved, and the scope of his studies is known only 
from quotes that appear in the writings of later authors. 
Aristotle is also mentioned among the potential discoverers 
of the pancreas [2 ], but we should note that his anatomical 
descriptions are rather superficial, and there is no mention
of the pancreas in his fundamental anatomical text, “The 
History of Animals” (Greek: Περ'ι τα ζώα ιστopiai, Latin: 
Historia Animalium) [3].
To the best of currently available knowledge, the term 
“pancreas” first appears in the works of Rufus of Ephesus, a 
first-century Greek doctor, who was probably the first to use 
this term to refer to this organ [2]. We should note, however, 
that at the time no function was attributed to the pancreas, 
and Rufus of Ephesus believed that the pancreas was only an 
extension of the digestive system.
The Middle Ages witnessed practically no progress in 
pancreas-related discoveries, except for Mondino dei Luzzi’s 
“Anatomy” [Anatomia], which went almost entirely unno­
ticed in the scientific world. In the course of describing 
two autopsies performed in 1315-16, dei Luizzi included a 
description that may have been referring to the pancreatic
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duct. Whether this was actually the case, however, remains a 
subject of intense controversy, and it is impossible to confirm 
his discovery [2].
Instead, historians give credit for discovering the pan­
creas to Johann Georg WirsUng [4 ]. On March 2nd, 1642, at 
the Saint Francis Hospital in Padua, he performed an autopsy 
on the body of a convict who was hanged the day before, and 
the autopsy was witnessed by Thomas Bartholin and Moritz 
Hoffman [2]. On the basis of his observations, Wirsung 
made a copperplate engraving showing the pancreatic duct. 
He then made copies and sent at least seven of them to 
leading anatomists of his time, including his former teacher, 
Professor Riolana. In the attached letters, Wirsung noted 
that the pancreatic duct perforates the duodenum right next 
to the bile duct. He also noted that inserting a probe into 
the pancreatic duct from the direction of the duodenum is 
difficult, while insertion from the luminal surface of the duct 
toward the duodenum encounters no difficulties. He then 
reflected on the function of the pancreas and the pancreatic 
duct, asking whether it is a type of a vein or artery, and 
simultaneously answering in the negative by stating that he 
has never observed blood in the pancreatic duct, while the 
fluid present in the duct dyed the silver probe similarly to bile 
[2, 5].
Moritz Hoffman, who was present during the dissection 
performed by Wirsung, also tried to take credit for discov­
ering the pancreatic duct. He claimed that in 1641, a year 
before Wirsung’s dissection, he discovered this duct during 
a dissection he performed on a turkey. Hoffman also claimed 
that Wirsung would not have paid attention to the duct if it 
had not been for their earlier conversation about the subject. 
The fact that Hoffman came forth with his claims five years 
after W irsung’s death, and six years after the dissection during 
which the latter had noticed and described the pancreatic 
duct, makes this episode particularly controversial [2].
Ultimately, Wirsung was credited with discovering the 
pancreatic duct, and it now bears his name [4 ]. Van Horne 
from Leiden was the first to use the term “Wirsung’s duct” in 
1685 [2].
Likewise, the accessory pancreatic duct was discovered by 
the Venatian Giovanni Domenico Santorini in 1724, and it is 
now referred to as Santorini’s duct [2, 4 ].
The initial steps toward discovering the role of the 
pancreas in digestive processes were associated with Regnier 
de G raaf’s seventeenth-century studies [6]. He was the first to 
perform the groundbreaking experiment of catheterizing the 
pancreatic duct in a living dog. A caterer made from a quill 
of a wild duck made it possible to collect pancreatic juice. 
Unfortunately, his imperfect experimental methods limited 
the possibility of describing the exact function of pancreatic 
juice. Upon an organoleptic examination of the juice, Ragnier 
de Graff decided that it had a bitter aftertaste, and on this basis 
proposed that it participates in the process of digesting food 
[2].
It was the French physiologist Claude Bernard who made 
significant progress in specifying the function played by 
the pancreas in digestive processes. His research, conducted 
between 1846 and 1849 showed how the pancreas participates 
in food digestion, with particular focus on how pancreatic
juice contributes to the digestion and absorption of fats [2 ]. 
Claude Bernard’s experiments were both elegantly conceived 
and replicable, as demonstrated by de Romo and Borgstein 
who replicated them on the basis of his methodology in 1999 
[7].
In 1869, Paul Langerhans, who studied medicine under 
Emile Du Bois-Reymond and was both a student and a 
friend of Rodolf Virchow, presented and published a disser­
tation entitled “Beitrage zur mikroskopischen Anatomie der 
Bauchspeicheldruse” (contributions to microscopic anatomy 
of the pancreas) [8]. In this work he not only described the 
existence of acinar cells in the pancreas but also noted the 
presence of small, polygonal cells in the parenchyma of the 
pancreas; these cells had a round nucleus and no nucleolus. 
They stained differently than cells in their surrounding and 
appeared in pairs or small clusters that formed islets in the sea 
of acinar cells. Langerhans also noted that the islets formed 
by the clusters of these cells were characterized by denser 
innervation than the rest of the pancreas [8].
Yet the function of these islets remained unknown. In 
1893, Gustave-Edouard Laguesse, a French histologist and 
pathologist, the first to refer to pancreatic islets as the islets 
of Langerhans, suggested that they might serve an endocrine 
function [8].
At the turn of the nineteenth and twentieth centuries, 
the studies of a number of scholars suggested that diabetes 
results from a lack of the hormone produced by the islets of 
Langerhans. Support for this hypothesis came from, among 
other things, the 1889 studies conducted by Josef von Mering 
and Oskar Minkowski, who showed that removing a dog’s 
pancreas caused it to develop diabetes [9, 10]. Sometime 
later, Eugene Lindsay Opie found morphological changes in 
pancreatic islets of patients who had suffered diabetes and 
died of it [11, 12].
Because of the suspicion that pancreatic islets are the 
source of a hormone that presumably prevents diabetes, 
Edward Albert Sharpey-Schafer, a British physiologist and 
one of the founders of endocrinology, called this hypothetical 
hormone insulin [13]. Researchers suspected that insulin 
controls glucose metabolism in the body and its lack leads 
to increased blood sugar levels, which, in turn, leads to the 
appearance of sugar in urine. Attempts were made to isolate 
insulin from the pancreas, but because of the presence of 
digestive enzymes in the exocrine part of the pancreas, these 
attempts proved fruitless. A breakthrough came only with 
the work of Frederick Grant Banting. In 1921, he approached 
John James Rickard Macleod, a physiology professor at the 
University of Toronto, and proposed to conduct studies 
focused on insulin [14]. His suggestion was to eliminate 
the exocrine part of the pancreas by ligation of exocrine 
ducts, which could make it possible to obtain tissue which 
had only small amounts of digestive enzymes and which 
was rich in pancreatic islets. Macleod accepted Banting’s 
proposal and, before leaving on summer break, gave him 
access to a lab, ten dogs, and the help of two medical 
students, Charles Herbert Best and E. Clark Noble [15]. 
Banting felt he only needed one helper, and Best and Noble 
decided to toss a coin. Luck favored Best. On May 16th, 
1921, Banting and Best commenced a series of experiments
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that led to the discovery of insulin. They initially sourced 
insulin from dog pancreases, then from pancreases harvested 
from cattle embryos, and finally from ox pancreases [16]. 
After Macleod returned from vacation he assumed oversight 
over the investigations [14]. The alcohol extract that Banting 
obtained from pancreases lowered glucose levels in dogs 
that had induced diabetes, but because the extracted insulin 
was relatively impure, it was unsuitable for clinical studies 
[16], which is why an experienced biochemist, James Betram 
Collip, joined the team in December 1921. Collip developed 
a successful method that enabled the extraction of large 
amounts of highly purified insulin from ox pancreases, and 
this made it possible for a clinical study to commence in 
January 1922. The study was a great success and confirmed 
insulin’s effectiveness in treating diabetes. In 1922, Banting, 
Best, and Collip were granted patent rights for producing 
insulin, but they sold them to the University of Toronto for 
a dollar [16]. In 1923, Frederick Grant Banting and John 
James Rickard Macleod were awarded the Nobel Prize in 
recognition of their discovery. Banting gave half of his prize 
money to Best, while Macleod gave half of his to Collip [14].
To the best of currently available knowledge, humans 
beyond the fetal stage have five types of endocrine cells in 
the islets of Langerhans: beta cells that produce insulin, alpha 
cells that produce glucagon, delta cells that produce som ato­
statin, PP cells that produce the pancreatic polypeptide, and 
ghrelin cells, responsible for the excretion of ghrelin [17]. The 
first study to suggest diversity among pancreatic islet cells 
was published by Lane in 1907 [18]. He differentiated two 
populations of cells, the A cells and B cells. In B cells, which 
are now known as beta cells, he found basophilic granules 
that were not present in A cells [19]. In 1957, Lacy and Davies
[19] used immunohistochemical methods to show that the 
hormone produced by beta cells is insulin. Later researchers 
used electron microscopy to determine the ultrastructure of 
beta cells; Like performed a study of human beta cells in 1967
[20].
In 1923, Kimball and Murlin reported that the pancreas 
produces a hormone with hyperglycemic effects [21]. It 
was later named glucagon, and its molecular structure was 
determined in the late 1950s [22]. The exact place where 
glucagon was produced in the islets of Langerhans remained 
unknown, however, and it was only in 1962 that Hellman et 
al. [23] used silver staining to show that among islet cells 
which Lane had described as A cells (i.e., not the beta cells), 
there are two cell populations: A1 and A2 [23]. A2 cells 
were later named alpha cells [23], and immunohistochemical 
studies have shown that they are the glucagon production site 
[24, 25].
Delta cells are another type of endocrine cells found 
within pancreatic islets, and they were first described by 
Bloom in 1931 [26]. He called them D cells and showed 
that they stain differently than either the A or the B cells 
described by Lane. In 1975, several research teams used 
immunohistochemical methods to show that delta cells 
produce somatostatin [27- 29].
Pancreatic polypeptide (PP) was discovered in 1968, in 
the course of attempts to isolate and purify chicken insulin 
[30]. Its presence was later confirmed in other animals
and humans [31]. The main effect of pancreatic polypeptide 
is the inhibition of exocrine functions of the pancreas, 
and pancreatic enzymes in particular. PP also inhibits the 
contracting activity of the gall bladder and has a variety 
of effects on the exocrine functions of the stomach [31]. 
Cells that produce pancreatic polypeptide (PP cells) were 
initially located within the islets of Langerhans in chickens 
with the help of immunohistochemical methods in 1974 [32]. 
They were later found in humans [33] and other animals 
[34]. In humans, PP cells are found primarily around the 
perimeter of pancreatic islets, and, in small numbers, also in 
the parenchyma of the exocrine part of the pancreas and the 
epithelium of pancreatic ducts [33].
In 1999, Kojima et al. [35] found ghrelin in the gastric 
m ucosa of humans and rats, and later studies found it in 
other animal species [35]. Ghrelin is produced primarily by 
the stomach, but it has also been found in other organs, 
including the intestines, pancreas, kidneys, hypothalamus, 
and the pituitary gland [35- 37]. In adult humans ghrelin- 
producing cells are found in small numbers in the islets of 
Langerhans, where they comprise approximately 1% of the 
cell population [17]. A small number of ghrelin cells are 
also found in the epithelium of pancreatic ducts and in the 
parenchyma of the exocrine part of the pancreas [17]. In 
contrast to adulthood, during the fetal and early childhood 
stages of human development ghrelin cells are much more 
numerous and comprise approximately 10% of the population 
of pancreatic islet cells [17]. Ghrelin has various biological 
functions; stimulation of food intake [38] and excretion 
of the growth hormone [35] are among those that were 
discovered earliest. Within the pancreas, ghrelin inhibits 
exocrine activity [39]. Most studies also suggest that it inhibits 
the secretion of insulin by beta cells [17, 40- 42]. Moreover, 
animal studies have shown that ghrelin has protective and 
healing effects on the pancreas. The administration of ghrelin 
inhibits the development of acute pancreatitis and limits 
damage to the pancreas [43, 44 ]. It also has therapeutic 
effects once acute pancreatitis develops and has been shown 
to hasten recovery [45].
2. Nobel Prizes
Pancreas research has led to significant developments in 
both pancreatology and general medicine, and since the 
establishment of the Nobel Prize in 1901, scientists studying 
the pancreas have been awarded the honor seven times 
[46 ]. Ivan Petrovich Pavlov was the first Nobel laureate to 
receive the prize for his work on the pancreas, among other 
things. He received the 1904 Nobel Prize in Physiology or 
Medicine, and, as the Committee wrote, it was “in recognition 
of his work on the physiology of digestion, through which 
knowledge on vital aspects of the subject has been trans­
formed and enlarged” [47]. Pavlov’s achievement consisted 
in discovering an automatic neurological regulation of the 
exocrine functions of the stomach and the pancreas. He also 
presented the mechanisms of the cephalic phase of pancreatic 
secretion, and his team discovered enterokinase and its role 
in the activation of trypsin [46, 48].
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The second Nobel Prize awarded for pancreas research 
was the already mentioned 1923 prize in Physiology or 
Medicine that went to Frederick Grant Banting and John 
James Macleod for discovering insulin [ 14].
The third was the 1946 Chemistry prize given to John H 
Northrup, whose colaureates were James Batcheller Sumner 
and Wendell Meredith Stanley in 1946 [49]. According to the 
Committee’s justification, Sumner received the prize “for his 
discovery that enzymes can be crystallized” while Northrup 
and Stanley received it “for their preparation of enzymes and 
virus proteins in a pure form” [49]. Northrup’s discoveries 
concerning the pancreas consisted in the crystallization of 
trypsin and trypsinogen, and the discovery and crystalliza­
tion of chymotrypsin [50].
The fourth Nobel Prize in pancreatic research was also a 
Chemistry prize that went to Frederick Sanger “for his work 
on the structure of proteins, especially that of insulin” [51].
In 1974, the Nobel Prize in Physiology or Medicine 
was awarded jointly to Albert Claude, Christian de Duve, 
and George E. Palade “for their discoveries concerning the 
structural and functional organization of the cell” [52]. 
Palade did his research on the ultrastructure of mitochondria, 
the endoplasmic reticulum, and ribosom es with the use of 
pancreatic acinar cells. He also characterized the structure 
of zymogen granules and examined the secretory pathway 
of these granules, from their formation on the rough endo­
plasmic reticulum, through posttranslational processing in 
the Golgi apparatus, to secretion out of the cell through 
exocytosis [53].
In 1977, Roger Guillemin, Andrew V. Schally, and Rosalyn 
Yalow were the corecipients of the Nobel Prize in Physiology 
or Medicine [54]. Guillemin and Schally received a quarter 
of the prize money each “for their discoveries concerning 
the peptide hormone production of the brain,” while the 
remaining half of the prize went to Rosalyn Yalow “for the 
development of radioimmunoassays of peptide hormones.” 
She used insulin in working out this method of assaying 
hormones [55].
The m ost recent and seventh Nobel Prize involving 
pancreas research was the 1999 Physiology or Medicine prize 
awarded to Gunter Blobel [56], who received it “for the 
discovery that proteins have intrinsic signals that govern their 
transport and localization in the cell.” Blobel used pancreatic 
acinar cells in the research that made this discovery possible 
[57].
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